POINT OF CARE MOLECULAR DIAGNOSTIC MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-127793 | Pharmaceutical And Healthcare
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Point of Care Molecular Diagnostic Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL POINT OF CARE MOLECULAR DIAGNOSTIC MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL POINT OF CARE MOLECULAR DIAGNOSTIC MARKET
7.1 GLOBAL POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA POINT OF CARE MOLECULAR DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Bayer Corporation
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Roche Diagnostics
16.3 Sysmex Corporation
16.4 Abaxis
16.5 Abbott Laboratories
16.6 BioMerieux SA
16.7 Bio-Rad Laboratories
16.8 Danaher Corporation
16.9 OraSure Technologies
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Market by Type :Polymerase Chain Reaction (Real Time PCR)
In Situ Hybridization
Chips and Microarrays
Mass Spectrometry
Sequencing
Isothermal Amplification
Others
Market by Application :
Hospitals
Diagnostic Laboratories
Research & Academic Laboratories
Companies
Bayer Corporation
Roche Diagnostics
Sysmex Corporation
Abaxis
Abbott Laboratories
BioMerieux SA
Bio-Rad Laboratories
Danaher Corporation
OraSure Technologies
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.